These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26096821)

  • 21. Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells.
    Zhou W; Capello M; Fredolini C; Piemonti L; Liotta LA; Novelli F; Petricoin EF
    J Proteome Res; 2010 Jun; 9(6):2929-36. PubMed ID: 20433201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
    Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
    Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW
    Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression.
    Alam MS; Gaida MM; Bergmann F; Lasitschka F; Giese T; Giese NA; Hackert T; Hinz U; Hussain SP; Kozlov SV; Ashwell JD
    Nat Med; 2015 Nov; 21(11):1337-43. PubMed ID: 26479921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia.
    Griggio V; Mandili G; Vitale C; Capello M; Macor P; Serra S; Castella B; Peola S; Foglietta M; Drandi D; Omedé P; Sblattero D; Cappello P; Chiarle R; Deaglio S; Boccadoro M; Novelli F; Massaia M; Coscia M
    Oncotarget; 2017 Jan; 8(2):3274-3288. PubMed ID: 27906678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay.
    Liberati D; Marzinotto I; Brigatti C; Dugnani E; Pasquale V; Reni M; Balzano G; Falconi M; Piemonti L; Lampasona V
    Cancer Biomark; 2018; 22(2):351-357. PubMed ID: 29660901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy.
    Fujii A; Yoneda M; Ito T; Yamamura O; Satomi S; Higa H; Kimura A; Suzuki M; Yamashita M; Yuasa T; Suzuki H; Kuriyama M
    J Neuroimmunol; 2005 May; 162(1-2):130-6. PubMed ID: 15833368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
    Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
    J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma.
    Niccolai E; Cappello P; Taddei A; Ricci F; D'Elios MM; Benagiano M; Bechi P; Bencini L; Ringressi MN; Coratti A; Cianchi F; Bonello L; Di Celle PF; Prisco D; Novelli F; Amedei A
    Int J Oncol; 2016 Jul; 49(1):393-401. PubMed ID: 27210467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models.
    Capello M; Cappello P; Linty FC; Chiarle R; Sperduti I; Novarino A; Salacone P; Mandili G; Naccarati A; Sacerdote C; Beghelli S; Bersani S; Barbi S; Bassi C; Scarpa A; Nisticò P; Giovarelli M; Vineis P; Milella M; Novelli F
    J Hematol Oncol; 2013 Sep; 6():67. PubMed ID: 24010981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum level of anti-α-enolase antibody in untreated systemic lupus erythematosus patients correlates with 24-hour urine protein and D-dimer.
    Li M; Li J; Wang J; Li Y; Yang P
    Lupus; 2018 Jan; 27(1):139-142. PubMed ID: 28728510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human cytomegalovirus-specific CD4(+) T-cell clones recognize cross-reactive peptides from the immediate early 1 protein.
    Le Roy E; Davignon JL
    Viral Immunol; 2005; 18(2):391-6. PubMed ID: 16035951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer.
    Kubuschok B; Neumann F; Breit R; Sester M; Schormann C; Wagner C; Sester U; Hartmann F; Wagner M; Remberger K; Schilling M; Pfreundschuh M
    Clin Cancer Res; 2006 Feb; 12(4):1365-72. PubMed ID: 16489095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of HLA-A*0201- and A*2402-restricted epitopes of mucin 5AC expressed in advanced pancreatic cancer.
    Yamazoe S; Tanaka H; Iwauchi T; Yoshii M; Ito G; Amano R; Yamada N; Sawada T; Ohira M; Hirakawa K
    Pancreas; 2011 Aug; 40(6):896-904. PubMed ID: 21697763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions.
    Amedei A; Niccolai E; Benagiano M; Della Bella C; Cianchi F; Bechi P; Taddei A; Bencini L; Farsi M; Cappello P; Prisco D; Novelli F; D'Elios MM
    Cancer Immunol Immunother; 2013 Jul; 62(7):1249-60. PubMed ID: 23640603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer.
    Hartmann N; Giese NA; Giese T; Poschke I; Offringa R; Werner J; Ryschich E
    Clin Cancer Res; 2014 Jul; 20(13):3422-33. PubMed ID: 24763614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival.
    Curcio C; Rosso T; Brugiapaglia S; Guadagnin G; Giordano D; Castellino B; Satolli MA; Spadi R; Campra D; Moro F; Papotti MG; Bertero L; Cassoni P; De Angelis C; Langella S; Ferrero A; Armentano S; Bellotti G; Fenocchio E; Nuzzo A; Ciccone G; Novelli F
    Clin Exp Med; 2023 Dec; 23(8):5089-5100. PubMed ID: 37910256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective HLA Class II Allele-Restricted Activation of Atabecestat Metabolite-Specific Human T-Cells.
    Ford M; Thomson PJ; Snoeys J; Meng X; Naisbitt DJ
    Chem Res Toxicol; 2024 Oct; 37(10):1712-1727. PubMed ID: 39348529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.